NEW YORK, June 5 – DeCode Genetics said Tuesday it has appointed Michael Young to the newly created position of vice president of business development.

In the new role, Young will be in charge of building the company’s corporate alliances for its research and product development programs.

Young, 49, previously worked at Genzyme Transgenics, where he was most recently vice president of commercial development. He has also worked as the head of business development at PerSeptive BioSystems and at Millipore.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.